The Linahert 5 Tablet, developed by Hertz Pharma, is an advanced diabetes care solution designed to help individuals with Type 2 diabetes achieve better blood sugar control. Formulated with Linagliptin, a powerful DPP-4 inhibitor, it enhances insulin secretion and reduces excessive glucose production in the liver, leading to stable glycemic levels. Its once-daily dosage offers convenience, while its weight-neutral and low hypoglycemia risk profile make it a safe choice for long-term diabetes management. Whether used alone or in combination with other treatments, Linahert 5 supports a healthier lifestyle, reinforcing Hertz Pharma’s commitment to quality and patient-centric healthcare.
